Global Alzheimer's Drugs Market 2019 by Manufacturers, Regions, Type and Application, Forecast to 2024
Table of Contents
1 Market Overview
- 1.1 Alzheimer's Drugs Introduction
- 1.2 Market Analysis by Type
- 1.2.1 Acetylcholinesterase (AChE) Inhibitors
- 1.2.2 Glutamate Inhibitors
- 1.2.3 Other
- 1.3 Market Analysis by Applications
- 1.3.1 Under 65 Years Old
- 1.3.2 65 and Above 65 Years Old
- 1.4 Market Analysis by Regions
- 1.4.1 North America (United States, Canada and Mexico)
- 1.4.1.1 United States Market States and Outlook (2014-2024)
- 1.4.1.2 Canada Market States and Outlook (2014-2024)
- 1.4.1.3 Mexico Market States and Outlook (2014-2024)
- 1.4.2 Europe (Germany, France, UK, Russia and Italy)
- 1.4.2.1 Germany Market States and Outlook (2014-2024)
- 1.4.2.2 France Market States and Outlook (2014-2024)
- 1.4.2.3 UK Market States and Outlook (2014-2024)
- 1.4.2.4 Russia Market States and Outlook (2014-2024)
- 1.4.2.5 Italy Market States and Outlook (2014-2024)
- 1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
- 1.4.3.1 China Market States and Outlook (2014-2024)
- 1.4.3.2 Japan Market States and Outlook (2014-2024)
- 1.4.3.3 Korea Market States and Outlook (2014-2024)
- 1.4.3.4 India Market States and Outlook (2014-2024)
- 1.4.3.5 Southeast Asia Market States and Outlook (2014-2024)
- 1.4.4 South America, Middle East and Africa
- 1.4.4.1 Brazil Market States and Outlook (2014-2024)
- 1.4.4.2 Egypt Market States and Outlook (2014-2024)
- 1.4.4.3 Saudi Arabia Market States and Outlook (2014-2024)
- 1.4.4.4 South Africa Market States and Outlook (2014-2024)
- 1.4.4.5 Turkey Market States and Outlook (2014-2024)
- 1.4.1 North America (United States, Canada and Mexico)
- 1.5 Market Dynamics
- 1.5.1 Market Opportunities
- 1.5.2 Market Risk
- 1.5.3 Market Driving Force
2 Manufacturers Profiles
- 2.1 Johnson & Johnson
- 2.1.1 Business Overview
- 2.1.2 Alzheimer's Drugs Type and Applications
- 2.1.2.1 Product A
- 2.1.2.2 Product B
- 2.1.3 Johnson & Johnson Alzheimer's Drugs Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
- 2.2 Novartis
- 2.2.1 Business Overview
- 2.2.2 Alzheimer's Drugs Type and Applications
- 2.2.2.1 Product A
- 2.2.2.2 Product B
- 2.2.3 Novartis Alzheimer's Drugs Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
- 2.3 Pfizer
- 2.3.1 Business Overview
- 2.3.2 Alzheimer's Drugs Type and Applications
- 2.3.2.1 Product A
- 2.3.2.2 Product B
- 2.3.3 Pfizer Alzheimer's Drugs Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
- 2.4 Eisai Pharmaceuticals
- 2.4.1 Business Overview
- 2.4.2 Alzheimer's Drugs Type and Applications
- 2.4.2.1 Product A
- 2.4.2.2 Product B
- 2.4.3 Eisai Pharmaceuticals Alzheimer's Drugs Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
- 2.5 Allergan
- 2.5.1 Business Overview
- 2.5.2 Alzheimer's Drugs Type and Applications
- 2.5.2.1 Product A
- 2.5.2.2 Product B
- 2.5.3 Allergan Alzheimer's Drugs Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
- 2.6 Amgen
- 2.6.1 Business Overview
- 2.6.2 Alzheimer's Drugs Type and Applications
- 2.6.2.1 Product A
- 2.6.2.2 Product B
- 2.6.3 Amgen Alzheimer's Drugs Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
- 2.7 Biogen
- 2.7.1 Business Overview
- 2.7.2 Alzheimer's Drugs Type and Applications
- 2.7.2.1 Product A
- 2.7.2.2 Product B
- 2.7.3 Biogen Alzheimer's Drugs Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
3 Global Alzheimer's Drugs Sales, Revenue, Market Share and Competition by Manufacturer (2017-2018)
- 3.1 Global Alzheimer's Drugs Sales and Market Share by Manufacturer (2017-2018)
- 3.2 Global Alzheimer's Drugs Revenue and Market Share by Manufacturer (2017-2018)
- 3.3 Market Concentration Rate
- 3.3.1 Top 3 Alzheimer's Drugs Manufacturer Market Share in 2018
- 3.3.2 Top 6 Alzheimer's Drugs Manufacturer Market Share in 2018
- 3.4 Market Competition Trend
4 Global Alzheimer's Drugs Market Analysis by Regions
- 4.1 Global Alzheimer's Drugs Sales, Revenue and Market Share by Regions
- 4.1.1 Global Alzheimer's Drugs Sales and Market Share by Regions (2014-2019)
- 4.1.2 Global Alzheimer's Drugs Revenue and Market Share by Regions (2014-2019)
- 4.2 North America Alzheimer's Drugs Sales and Growth Rate (2014-2019)
- 4.3 Europe Alzheimer's Drugs Sales and Growth Rate (2014-2019)
- 4.4 Asia-Pacific Alzheimer's Drugs Sales and Growth Rate (2014-2019)
- 4.5 South America Alzheimer's Drugs Sales and Growth Rate (2014-2019)
- 4.6 Middle East and Africa Alzheimer's Drugs Sales and Growth Rate (2014-2019)
5 North America Alzheimer's Drugs by Country
- 5.1 North America Alzheimer's Drugs Sales, Revenue and Market Share by Country
- 5.1.1 North America Alzheimer's Drugs Sales and Market Share by Country (2014-2019)
- 5.1.2 North America Alzheimer's Drugs Revenue and Market Share by Country (2014-2019)
- 5.2 United States Alzheimer's Drugs Sales and Growth Rate (2014-2019)
- 5.3 Canada Alzheimer's Drugs Sales and Growth Rate (2014-2019)
- 5.4 Mexico Alzheimer's Drugs Sales and Growth Rate (2014-2019)
6 Europe Alzheimer's Drugs by Country
- 6.1 Europe Alzheimer's Drugs Sales, Revenue and Market Share by Country
- 6.1.1 Europe Alzheimer's Drugs Sales and Market Share by Country (2014-2019)
- 6.1.2 Europe Alzheimer's Drugs Revenue and Market Share by Country (2014-2019)
- 6.2 Germany Alzheimer's Drugs Sales and Growth Rate (2014-2019)
- 6.3 UK Alzheimer's Drugs Sales and Growth Rate (2014-2019)
- 6.4 France Alzheimer's Drugs Sales and Growth Rate (2014-2019)
- 6.5 Russia Alzheimer's Drugs Sales and Growth Rate (2014-2019)
- 6.6 Italy Alzheimer's Drugs Sales and Growth Rate (2014-2019)
7 Asia-Pacific Alzheimer's Drugs by Country
- 7.1 Asia-Pacific Alzheimer's Drugs Sales, Revenue and Market Share by Country
- 7.1.1 Asia-Pacific Alzheimer's Drugs Sales and Market Share by Country (2014-2019)
- 7.1.2 Asia-Pacific Alzheimer's Drugs Revenue and Market Share by Country (2014-2019)
- 7.2 China Alzheimer's Drugs Sales and Growth Rate (2014-2019)
- 7.3 Japan Alzheimer's Drugs Sales and Growth Rate (2014-2019)
- 7.4 Korea Alzheimer's Drugs Sales and Growth Rate (2014-2019)
- 7.5 India Alzheimer's Drugs Sales and Growth Rate (2014-2019)
- 7.6 Southeast Asia Alzheimer's Drugs Sales and Growth Rate (2014-2019)
8 South America Alzheimer's Drugs by Country
- 8.1 South America Alzheimer's Drugs Sales, Revenue and Market Share by Country
- 8.1.1 South America Alzheimer's Drugs Sales and Market Share by Country (2014-2019)
- 8.1.2 South America Alzheimer's Drugs Revenue and Market Share by Country (2014-2019)
- 8.2 Brazil Alzheimer's Drugs Sales and Growth Rate (2014-2019)
- 8.3 Argentina Alzheimer's Drugs Sales and Growth Rate (2014-2019)
- 8.4 Colombia Alzheimer's Drugs Sales and Growth Rate (2014-2019)
9 Middle East and Africa Alzheimer's Drugs by Countries
- 9.1 Middle East and Africa Alzheimer's Drugs Sales, Revenue and Market Share by Country
- 9.1.1 Middle East and Africa Alzheimer's Drugs Sales and Market Share by Country (2014-2019)
- 9.1.2 Middle East and Africa Alzheimer's Drugs Revenue and Market Share by Country (2014-2019)
- 9.2 Saudi Arabia Alzheimer's Drugs Sales and Growth Rate (2014-2019)
- 9.3 Turkey Alzheimer's Drugs Sales and Growth Rate (2014-2019)
- 9.4 Egypt Alzheimer's Drugs Sales and Growth Rate (2014-2019)
- 9.5 Nigeria Alzheimer's Drugs Sales and Growth Rate (2014-2019)
- 9.6 South Africa Alzheimer's Drugs Sales and Growth Rate (2014-2019)
10 Global Alzheimer's Drugs Market Segment by Type
- 10.1 Global Alzheimer's Drugs Sales, Revenue and Market Share by Type (2014-2019)
- 10.1.1 Global Alzheimer's Drugs Sales and Market Share by Type (2014-2019)
- 10.1.2 Global Alzheimer's Drugs Revenue and Market Share by Type (2014-2019)
- 10.2 Acetylcholinesterase (AChE) Inhibitors Sales Growth and Price
- 10.2.1 Global Acetylcholinesterase (AChE) Inhibitors Sales Growth (2014-2019)
- 10.2.2 Global Acetylcholinesterase (AChE) Inhibitors Price (2014-2019)
- 10.3 Glutamate Inhibitors Sales Growth and Price
- 10.3.1 Global Glutamate Inhibitors Sales Growth (2014-2019)
- 10.3.2 Global Glutamate Inhibitors Price (2014-2019)
- 10.4 Other Sales Growth and Price
- 10.4.1 Global Other Sales Growth (2014-2019)
- 10.4.2 Global Other Price (2014-2019)
11 Global Alzheimer's Drugs Market Segment by Application
- 11.1 Global Alzheimer's Drugs Sales Market Share by Application (2014-2019)
- 11.2 Under 65 Years Old Sales Growth (2014-2019)
- 11.3 65 and Above 65 Years Old Sales Growth (2014-2019)
12 Alzheimer's Drugs Market Forecast (2019-2024)
- 12.1 Global Alzheimer's Drugs Sales, Revenue and Growth Rate (2019-2024)
- 12.2 Alzheimer's Drugs Market Forecast by Regions (2019-2024)
- 12.2.1 North America Alzheimer's Drugs Market Forecast (2019-2024)
- 12.2.2 Europe Alzheimer's Drugs Market Forecast (2019-2024)
- 12.2.3 Asia-Pacific Alzheimer's Drugs Market Forecast (2019-2024)
- 12.2.4 South America Alzheimer's Drugs Market Forecast (2019-2024)
- 12.2.5 Middle East and Africa Alzheimer's Drugs Market Forecast (2019-2024)
- 12.3 Alzheimer's Drugs Market Forecast by Type (2019-2024)
- 12.3.1 Global Alzheimer's Drugs Sales Forecast by Type (2019-2024)
- 12.3.2 Global Alzheimer's Drugs Market Share Forecast by Type (2019-2024)
- 12.4 Alzheimer's Drugs Market Forecast by Application (2019-2024)
- 12.4.1 Global Alzheimer's Drugs Sales Forecast by Application (2019-2024)
- 12.4.2 Global Alzheimer's Drugs Market Share Forecast by Application (2019-2024)
13 Sales Channel, Distributors, Traders and Dealers
- 13.1 Sales Channel
- 13.1.1 Direct Marketing
- 13.1.2 Indirect Marketing
- 13.1.3 Marketing Channel Future Trend
- 13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
- 15.1 Methodology
Scope of the Report:
The worldwide market for Alzheimer's Drugs is expected to grow at a CAGR of roughly over the next five years, will reach million US$ in 2024, from million US$ in 2019, according to a new GIR (Global Info Research) study.
This report focuses on the Alzheimer's Drugs in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.
Market Segment by Manufacturers, this report covers
Johnson & Johnson
Novartis
Pfizer
Eisai Pharmaceuticals
Allergan
Amgen
Biogen
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
Acetylcholinesterase (AChE) Inhibitors
Glutamate Inhibitors
Other
Market Segment by Applications, can be divided into
Under 65 Years Old
65 and Above 65 Years Old
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Alzheimer's Drugs product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Alzheimer's Drugs, with price, sales, revenue and global market share of Alzheimer's Drugs in 2017 and 2018.
Chapter 3, the Alzheimer's Drugs competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Alzheimer's Drugs breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2014 to 2019.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2014 to 2019.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2014 to 2019.
Chapter 12, Alzheimer's Drugs market forecast, by regions, type and application, with sales and revenue, from 2019 to 2024.
Chapter 13, 14 and 15, to describe Alzheimer's Drugs sales channel, distributors, customers, research findings and conclusion, appendix and data source.